Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PIRS Stock Annual Cash Flow. Download in Excel

Pieris Pharmaceuticals Inc. logo

Pieris Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

17.30
 
USD
  
0.05
  
(0.29%)
Previous close: 17.25  Open: 17.25  Bid: 17.0  Ask: 17.6
52 week range    
6.20   
   23.20
Mkt Cap: 22 M  Avg Vol (90 Days): 25,011
Peers   
IMUC / 
CSBR / 
AEZS / 
Last updated: Monday 4th November 2024

Stock Rankings

56
MarketXLS Rank
60
Value
61
Technical
47
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

PIRS Cash Flow

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current liabilities-14 M20 M-20 M-40 M
(Increase) Decrease in payables-4 M7 M-4 M-789000.0
(Increase) Decrease in receivables5 M-2 M-3 M5 M
AssetImpairmentCharge14 M
CapitalExpenditureReported3 M949000.01 M171000.0
Cash at beginning of period62 M70 M118 M39 M
Cash at end of period70 M70 M39 M17 M
Cash flow-46 M-8 M-60 M-54 M
CashFlowFromContinuingInvestingActivities39 M-949000.0-21 M12 M
ChangeInAccountPayable-4 M7 M-4 M-789000.0
ChangeInAccruedExpense-2 M10 M-4 M-2 M
ChangeInPayablesAndAccruedExpense-6 M17 M-8 M-3 M
ChangeInPrepaidAssets-500000.0-3 M-1 M1 M
ChangeInWorkingCapital-16 M32 M-32 M-37 M
ChangesInAccountReceivables5 M-2 M-3 M5 M
Current deferred income taxes164000.0
Deferred income taxes164000.0
Depreciation2 M3 M2 M
Depreciation unreconciled2 M2 M3 M2 M
DepreciationAndAmortization-184000.02 M3 M2 M
Effect of exchange rate changes5 M-3 M-5 M783000.0
FinancingCashFlow10 M59 M7 M20 M
Free cash flow-49 M-9 M-61 M-54 M
GainLossOnInvestmentSecurities471000.0-376000.0-53000.0
Issuance of capital stock10 M57 M7 M20 M
IssuanceOfCapitalStock10 M57 M7 M20 M
Net cash from financing activities10 M59 M7 M20 M
Net cash from investing activities39 M-949000.0-21 M12 M
Net cash from operating activities-46 M-8 M-60 M-54 M
Net change in cash & cash equivalents8 M47 M-74 M-22 M
Net income from continuing operations-37 M-46 M-33 M-25 M
NetCommonStockIssuance10 M57 M7 M20 M
NetForeignCurrencyExchangeGainLoss-8000.0
NetInvestmentPropertiesPurchaseAndSale42 M-20 M12 M
NetInvestmentPurchaseAndSale42 M-20 M12 M
NetPPEPurchaseAndSale-3 M-949000.0-1 M-171000.0
NetPreferredStockIssuance10 M
Operating (gains) losses463000.0-376000.0-53000.0
Other non-cash items4 M4 M3 M6 M
PreferredStockIssuance10 M
ProceedsFromIssuanceOfWarrants837000.0
ProceedsFromStockOptionExercised291000.01 M95000.0
Purchase of Float term investments-41 M-48 M-23 M
Purchase of property plant & equipment-3 M-949000.0-1 M-171000.0
PurchaseOfInvestment-41 M-48 M-23 M
PurchaseOfPPE-3 M-949000.0-1 M-171000.0
Revenue per share-184000.0-91000.0
Sale of short term investments83 M28 M35 M
SaleOfInvestment83 M28 M35 M
StockBasedCompensation5 M5 M4 M3 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University